Derma

Global Facial Injectable Market Analysis, Size & Forecast Report, 2022-2023 & 2028: Growing Demand for Youthful Beauty - Derma Fillers Lead the Market with Fastest Growth Rate - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 14, 2023

In 2022, the global facial injectables market was valued at US$7.81 billion, and is probable to reach US$15.93 billion by 2028.

Key Points: 
  • In 2022, the global facial injectables market was valued at US$7.81 billion, and is probable to reach US$15.93 billion by 2028.
  • The global facial injectables market value is projected to grow at a CAGR of 12.60%, during the forecast period of 2023-2028.
  • Furthermore, the facial injectable market is predicted to grow as the senior population grows and new facial injectables, such as synthetic calcium hydroxylaptite (CaHA) fillers, become available.
  • By Type: According to the report, the global facial injectables market is segmented into two types : Derma Fillers and Neuromodulator Aesthetics.

DERMA E Launches New Pure Biome Skincare Line

Retrieved on: 
Wednesday, March 1, 2023

Vegan, natural, proven clean beauty skincare brand DERMA E is excited to announce the launch of their new Pure Biome Skincare line, designed for those with skin sensitivities, to help strengthen and protect the skin barrier.

Key Points: 
  • Vegan, natural, proven clean beauty skincare brand DERMA E is excited to announce the launch of their new Pure Biome Skincare line, designed for those with skin sensitivities, to help strengthen and protect the skin barrier.
  • The dermatologist-recommended Pure Biome line —which features the Pure Biome Balancing Cleanser , Pure Biome Balancing Cream , Pure Biome Balancing Serum and Pure Biome Balancing Eye Cream — is uniquely infused with a proprietary sensitive biotic system made up of prebiotics, probiotics, antioxidant-rich Cica and Pycnogenol® to help strengthen against the appearance of redness and dryness resulting from an imbalanced, weakened microbiome.
  • We’re so proud to be launching our new Pure Biome Skincare Line, designed specifically to support the strengthening & balancing of the microbiome for those who suffer from skin sensitivities.
  • The Derma E Pure Biome Skincare line will launch exclusively on DERMAE.com and retail between $16.50-$29.95.

medicube Takes Luxury Skincare to New Heights for Holiday with the Launch of First-Ever Primrose Pink Edition AGE-R Device Trio

Retrieved on: 
Monday, December 19, 2022

Age-R beauty devices come in luminous, luxurious tones as part of the medicube identity as the mecca of at-home beauty instruments – upgrade your skincare and your vanity with the limited-edition Primrose Pink Edition AGE-R Device Trio .

Key Points: 
  • Age-R beauty devices come in luminous, luxurious tones as part of the medicube identity as the mecca of at-home beauty instruments – upgrade your skincare and your vanity with the limited-edition Primrose Pink Edition AGE-R Device Trio .
  • The South Korean-based brand offers an assortment of top-performing, clinically-backed tools and skincare, with each collection focusing on your individual skincare needs.
  • The medicube Primrose Pink Edition AGE-R Device Trio is available for sale now on medicube.com for $880.
  • Primrose Pink Edition AGE-R Device Trio will be available from now through Valentine's Day 2023.

Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product

Retrieved on: 
Wednesday, June 15, 2022

Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors, from its fill and finish facility in Stein, Switzerland

Key Points: 
  • Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors, from its fill and finish facility in Stein, Switzerland
    TOULOUSE, France, June 15, 2022 /PRNewswire/ --Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, and French pharmaceutical group Pierre Fabre announced today that the companies have entered into a manufacturing agreement.
  • Lonza will provide cGMP drug product (DP) manufacturing services for clinical supply from its fill and finish facility at Stein, Switzerland.
  • Jean-Luc Lowinski, Pierre Fabre Medical Care CEO, said: "We are delighted to entrust the production of the W0180 Drug Product to Lonza.
  • Its portfolio includes several medical franchises and international brands, including Pierre Fabre Oncology, Pierre Fabre Dermatology, Eau Thermale Avne, Klorane, Ducray, Ren Furterer, A-Derma and Pierre Fabre Oral Care.

Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product

Retrieved on: 
Wednesday, June 15, 2022

Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors, from its fill and finish facility in Stein, Switzerland

Key Points: 
  • Lonza will provide clinical drug product manufacturing for W0180, an oncology drug candidate discovered by Pierre Fabre targeting solid tumors, from its fill and finish facility in Stein, Switzerland
    TOULOUSE, France, June 15, 2022 /PRNewswire/ --Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, and French pharmaceutical group Pierre Fabre announced today that the companies have entered into a manufacturing agreement.
  • Lonza will provide cGMP drug product (DP) manufacturing services for clinical supply from its fill and finish facility at Stein, Switzerland.
  • Jean-Luc Lowinski, Pierre Fabre Medical Care CEO, said: "We are delighted to entrust the production of the W0180 Drug Product to Lonza.
  • Its portfolio includes several medical franchises and international brands, including Pierre Fabre Oncology, Pierre Fabre Dermatology, Eau Thermale Avne, Klorane, Ducray, Ren Furterer, A-Derma and Pierre Fabre Oral Care.

The Skin’s Microbiome Needs a Healthy Balance of Bacteria to Stay Fresh and Vibrant

Following the popularity of eating yogurt filled with probiotics to keep your gut healthy, the skincare industry realized the microbiome needs a healthy balance of good bacteria to keep it fresh and slow the aging process.

Key Points: 
  • Following the popularity of eating yogurt filled with probiotics to keep your gut healthy, the skincare industry realized the microbiome needs a healthy balance of good bacteria to keep it fresh and slow the aging process.
  • When your microbiome becomes unbalanced with bad bacteria, your skin may develop blemishes and rashes, Dr. Bezouka said.
  • Derma.Ferm ACUTE, which provides a single microemulsion for a healthy skin microbiome, contains natural skin hydrating compounds that are supported by a cleaning enzyme complex.
  • Our products restore a healthy balance to the skins microbiome.

Lutronic Changes the Game with the Derma V Dermatology Platform

Retrieved on: 
Thursday, October 28, 2021

BOSTON, Oct. 28, 2021 /PRNewswire/ -- Lutronic, the global leader in intelligent, energy-based systems for medical aesthetics, introduces Derma V, a ground-breaking dermatology workstation.

Key Points: 
  • BOSTON, Oct. 28, 2021 /PRNewswire/ -- Lutronic, the global leader in intelligent, energy-based systems for medical aesthetics, introduces Derma V, a ground-breaking dermatology workstation.
  • Derma V has completely redefined the dermatology workstation.
  • These things, plus ICD cooling and IntelliTrack, differentiate Lutronic's state-of-the-art Derma V dermatology workstation from the rest, and set a new global standard for platform laser technology."
  • Committed to this mission, Lutronic partners with key opinion leaders to advance the science and efficacy of Lutronic's systems.

BiomCare’s New Skincare Products That Restore A Healthy Balance to Your Skin’s Microbiome Are Coming Soon to America

People dont realize that your skins microbiome or microbiota is an ecosystem of bacteria on your skins surface.

Key Points: 
  • People dont realize that your skins microbiome or microbiota is an ecosystem of bacteria on your skins surface.
  • To keep your skin looking and feeling healthy, you need to keep your microbiome in balance.
  • Derma.Ferm ACUTE, which provides a single microemulsion for a healthy skin microbiome, contains natural skin hydrating compounds that are supported by a cleaning enzyme complex.
  • COVID-19 forced everyone to think about their health, which is why we believe consumers want safe and healthy skincare protection, Drs.

MesoLyft Is The Skincare Brand Redefining Anti-Aging At-Home Treatments Face Resurfacing Derma Roller May Help Accelerate Skin's Natural Repair Process

Retrieved on: 
Wednesday, June 9, 2021

BOSTON, June 9, 2021 /PRNewswire/ --MesoLyft, an innovative clean, sustainable skincare brand, recently launched the Mesolyft Face Resurfacing Derma Roller.

Key Points: 
  • BOSTON, June 9, 2021 /PRNewswire/ --MesoLyft, an innovative clean, sustainable skincare brand, recently launched the Mesolyft Face Resurfacing Derma Roller.
  • This wrinkle-relaxing product may help accelerate the skin's natural repair process with its proprietary formula of ingredients.
  • MesoLyft has introduced the first all-in-one wrinkle-relaxing derma roller that combines clean skincare and science with its 0.15 mm micro-needle derma roller.
  • The wrinkle-relaxing product consists of a natural blend of Retinol, Vitamin E, Vitamin C, Sunflower Seed Oil, and Hyaluronic Acid.

Derma AI Earns CE Mark Approval

Retrieved on: 
Thursday, May 27, 2021

PERTH, Australia, May 27, 2021 /PRNewswire/ --Advanced Human Imaging Limited (ASX: AHI) ("AHI" or the "Company") is pleased to announce the Derma AI embedded in the AHI DermaScan has received CE Mark clearance in the European Union for the dermatology AI component in CompleteScan.

Key Points: 
  • PERTH, Australia, May 27, 2021 /PRNewswire/ --Advanced Human Imaging Limited (ASX: AHI) ("AHI" or the "Company") is pleased to announce the Derma AI embedded in the AHI DermaScan has received CE Mark clearance in the European Union for the dermatology AI component in CompleteScan.
  • The Derma AI component (DermaScan AI) can accurately classify skin conditions from an image captured on a standard smartphone camera.
  • In April, AHI announced a significant equity stake in Triage and a deal to integrate Derma AI into the AHI-owned and patented CompleteScan SaaS platform.
  • As we stand today, I am proud to say we have achieved this with Derma AI.